Ajanta Pharma has launched eletriptan hydrobromide tablets in the US market. The drug is a bioequivalent generic version of Relpax tablets and the company has launched the product in two strengths, 20 mg and 40 mg tablets. The drug is used to treat headache. Ajanta has 35 Abbreviated New Drug Applications (ANDAs) of which it has 19 final ANDA approvals, two tentative approvals, and 14 ANDAs under review with US FDA. So far it has launched 14 products in the US market.
Company Profile : Ajanta Pharma Ltd
Leave a Reply